Atezolizumab and Stereotactic Body Radiation in Metastatic, Recurrent, or Persistent Cervical Cancer: Results From a Phase 2 Multi-Institutional Study.

Saved in:
Bibliographic Details
Title: Atezolizumab and Stereotactic Body Radiation in Metastatic, Recurrent, or Persistent Cervical Cancer: Results From a Phase 2 Multi-Institutional Study.
Authors: Ahmed KA; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida. Electronic address: kamran.ahmed@moffitt.org., Quick AM; Department of Radiation Oncology, Ohio State, University, Ohio State University, Columbus, Ohio., Chon HS; Department of Gynecologic Oncology, Moffitt Cancer Center, Tampa, Florida., Chern JY; Department of Gynecologic Oncology, Moffitt Cancer Center, Tampa, Florida., Bixel K; Department of Gynecologic Oncology, Stanford University, Palo Alto, California., Kim Y; Department of Biostatistics, Moffitt Cancer Center, Tampa, Florida., Li J; Department of Biostatistics, Moffitt Cancer Center, Tampa, Florida., Montejo ME; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida., Dowell RA; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida., Kim S; Department of Radiation Oncology, Mayo Clinic Jacksonville, Jacksonville, Florida., Fernandez DC; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida., Lam CA; Department of Radiology, Moffitt Cancer Center, Tampa, Florida., Hakam A; Department of Pathology, Moffitt Cancer Center, Tampa, Florida., Rosa M; Department of Pathology, Moffitt Cancer Center, Tampa, Florida., Shafique M; Department of Gynecologic Oncology, Moffitt Cancer Center, Tampa, Florida., Shahzad MM; Department of Gynecologic Oncology, Moffitt Cancer Center, Tampa, Florida., Wenham RM; Department of Gynecologic Oncology, Moffitt Cancer Center, Tampa, Florida.
Source: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2026 May 01; Vol. 125 (1), pp. 298-305. Date of Electronic Publication: 2025 May 14.
Publication Type: Journal Article; Multicenter Study; Clinical Trial, Phase II; Research Support, N.I.H., Extramural
Journal Info: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-355X
DOI:10.1016/j.ijrobp.2025.05.003